The transferrin receptor binding site on HFE, the class I MHC-related protein mutated in hereditary hemochromatosis

Journal of Molecular Biology

Volumn 289, Issue 4, 1999, Pages 1109-1118

  Lebrón, José A ^b   Bjorkman, Pamela J ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b NONE

Author keywords

Class I MHC homolog; Functional epitope; Iron overload; pH dependent affinity; Surface plasmon resonance

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSFERRIN RECEPTOR;

ARTICLE; BINDING SITE; BIOSENSOR; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; HEMOCHROMATOSIS; HUMAN; LIGAND BINDING; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0033020518     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2842     Document Type: Article

References (40)

1. Andrews N. C., Levy J. E. Iron is hot: an update on the pathophysiology of hemochromatosis. Blood. 92:1998;1845-1851.
2. Bebbington C. R., Hentschel C. C. G. The use of vectors based on gene amplification for the expression of cloned genes in mammalian cells. Glover D. M. DNA Cloning: A Practical Approach. 1987;163-188 IRL Press, Oxford.
3. +T-cells. Nature. 372:1994;691-694.
4. Burmeister W. P., Huber A. H., Bjorkman P. J. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature. 372:1994;379-383.
5. Casta ñ A. R., Tangri S., Miller J. E., Holcombe H. R., Jackson M. R., Huse W. D., Kronenberg M., Peterson P. A. Peptide binding and presentation by mouse CD1. Science. 269:1995;223-226.
6. Colonna M., Borsellino G., Falco M., Ferrara G. B., Strominger J. L. HLA-C is the inhibitory ligand that determines domain resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl Acad. Sci. USA. 90:1993;12000-12004.
7. Cuthbert J. A. Iron, HFE, and hemochromatosis update. J. Invest. Med. 45:1997;518-529.
8. Dall'Acqua W., Goldman E. R., Eisenstein E., Mariuzza R. A. A mutational analysis of the binding of two different proteins to the same antibody. Biochemistry. 35:1996;9667-9676.
9. DeMaurex N., Furuya W., Dsouza S., Bonifacino J. S., Grinstein S. Mechanism of acidification of the trans-Golgi network (TGN)- in situ measurements of pH using retrieval of TGN38 and furin from the cell surface. J. Biol. Chem. 273:1998;2044-2051.
10. Fahnestock M. L., Tamir I., Narhi L., Bjorkman P. J. Thermal stability comparison of purified empty and peptide filled forms of a class I MHC molecule. Science. 258:1992;1658-1662.
11. Feder J. N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D. A., Basava A., Dormishian F., Domingo R., Ellis M. C., Fullan A., Hinton L. M., Jones N. L., Kimmel B. E., Kronmal G. S., Lauer P. et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet. 13:1996;399-408.
12. Feder J. N., Tsuchihashi Z., Irrinki A., Lee V. K., Mapa F. A., Morikang E., Prass C. E., Starnes S. M., Wolff R. K., Parkkila S., Sly W. S., Schatzman R. C. The hemochromatosis founder mutation in HLA-H disrupts β2-microglobulin interaction and cell surface expression. J. Biol. Chem. 272:1997;14025-14028.
13. Feder J. N., Penny D. M., Irrinki A., Lee V. K., Lebrón J. A., Watson N., Tsuchihashi Z., Sigal E., Bjorkman P. J., Schatzman R. C. The hemochromatosis gene product complexes with the transferrin receptor, and lowers its affinity for ligand binding. Proc. Natl Acad. Sci. USA. 95:1998;1472-1477.
14. Fersht A. Enzyme Structure and Mechanism. 1985;W. H. Freeman and Company, New York.
15. Gao G. F., Tormo J., Gerth U. C., Wyer J. R., McMichael A. J., Stuart D. I., Bell J. I., Jones E. Y., Jakobsen B. K. Crystal structure of the complex between CD8αα and HLA-A2. Nature. 387:1997;630-634.
16. Gastinel L. N., Simister N. E., Bjorkman P. J. Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules. Proc. Natl Acad. Sci. USA. 89:1992;638-642.
17. Gross C. N., Irrinki A., Feder J. N., Enns C. A. Co-trafficking of HFE, a non-classical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J. Biol. Chem. 273:1998;22068-22074.
18. Hashimoto K., Hirai M., Kurosawa Y. Identification of a mouse homolog for the human hereditary haemochromatosis candidate gene. Biochem. Biophys. Res. Commun. 230:1997;35-39.
19. Howard J. B., Rees D. C. Perspectives on non-heme iron protein chemistry. Advan. Protein Chem. 42:1991;199-280.
20. Junghans R. P. Finally! The brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG. Immunol. Res. 16:1997;29-57.
21. Karlsson R., Fält A. Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. J. Immunol. Methods. 200:1997;121-133.
22. Kelley R. F., O'Connell M. P. Thermodynamic analysis of an antibody functional epitope. Biochemistry. 32:1993;6828-6835.
23. Kunkel T. A., Roberts J. D., Zakour R. A. Rapid and efficient site directed mutagenesis without phenotypic selection. Methods Enzymol. 154:1987;367-382.
24. Lebrón J. A., Bennett M. J., Vaughn D. E., Chirino A. J., Snow P. M., Mintier G. A., Feder J. N., Bjorkman P. J. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell. 93:1998;111-123.
25. Lebrón J. A., Shen H., Bjorkman P. J., Ou S. Tolerization of adult mice to immunodominant proteins before monoclonal antibody production. J. Immunol. Methods. 222:1999;59-63.
26. Llopid J., McCaffery J. M., Miyawaki A., Farquhar M. G., Tsien R. Y. Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc. Natl Acad. Sci. USA. 95:1998;6803-6808.
27. Madden D. R. The three dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:1995;587-622.
28. Malmqvist M. Biospecific interaction analysis using biosensor technology. Nature. 361:1993;186-187.
29. Mukherjee S., Ghosh R. N., Maxfield F. R. Endocytosis. Physiol. Rev. 77:1997;759-803.
30. Parkkila S., Waheed A., Britton R. S., Bacon B. R., Zhou X. Y., Tomatsu S., Fleming R. E., Sly W. S. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc. Natl Acad. Sci. USA. 94:1997;13198-13202.
31. Richardson D. R., Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta. 1331:1997;1-40.
32. Stagsted J., Reaven G. M., Hansen T., Goldstein A., Olsson L. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen. Cell. 62:1990;297-307.
33. Stagsted J., Mapelli C., Meyers C., Matthews B. W., Anfinsen C. B., Goldstein A., Olsson L. Amino acid residues essential for biological activity of a peptide derived from a major histocompatibility complex class I antigen. Proc. Natl Acad. Sci. USA. 90:1993;7686-7690.
34. Tsumoto K., Ogasahara K., Ueda Y., Watanabe K., Yutani K., Kumagai I. Role of Tyr residues in the contact region of anti-lysozyme monoclonal antibody HyHEL10 for antigen binding. J. Biol. Chem. 270:1995;18551-18557.
35. Vaughn D. E., Bjorkman P. J. High affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization. Biochemistry. 36:1997;9374-9380.
36. Vaughn D. E., Bjorkman P. J. Structural basis of pH-dependent antibody binding by the neonatal Fc receptor. Structure. 6:1998;63-73.
37. Vaughn D. E., Milburn C. M., Penny D. M., Martin W. L., Johnson J. L., Bjorkman P. J. Identification of critical IgG binding epitopes on the neonatal Fc receptor. J. Mol. Biol. 274:1997;597-607.
38. Waheed A., Parkkila S., Zhou X. Y., Tomatsu S., Tsuchihashi Z., Feder J. N., Schatzman R. C., Britton R. S., Bacon B. R., Sly W. S. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with β2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc. Natl Acad. Sci. USA. 94:1997;12384-12389.
39. Wells J. A., DeVos A. M. Hematopoietic receptor complexes. Annu. Rev. Biochem. 65:1996;609-634.
40. Wilson I. A., Bjorkman P. J. Unusual MHC-like molecules: CD1, Fc receptor, the hemochromatosis gene product, and viral homologs. Curr. Opin. Immunol. 10:1998;67-73.